Aileron Therapeutics, Inc. (NASDAQ:ALRN – Get Free Report) was the recipient of a significant decline in short interest during the month of December. As of December 15th, there was short interest totalling 110,600 shares, a decline of 38.1% from the November 30th total of 178,800 shares. Based on an average daily volume of 83,200 shares, […]

Akebia Therapeutics, Inc. (NASDAQ:AKBA – Get Free Report) was the recipient of a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 14,070,000 shares, a growth of 21.7% from the November 30th total of 11,560,000 shares. Based on an average daily trading volume, of 1,990,000 […]

Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) saw a large decrease in short interest during the month of December. As of December 15th, there was short interest totalling 36,100 shares, a decrease of 31.6% from the November 30th total of 52,800 shares. Based on an average daily trading volume, of 45,100 shares, the short-interest […]

Atossa Therapeutics, Inc. (NASDAQ:ATOS – Get Free Report) was the target of a large drop in short interest in December. As of December 15th, there was short interest totalling 8,200,000 shares, a drop of 29.3% from the November 30th total of 11,600,000 shares. Based on an average daily volume of 705,500 shares, the short-interest ratio […]

Eterna Therapeutics Inc. (NASDAQ:ERNA – Get Free Report) was the recipient of a significant increase in short interest in December. As of December 15th, there was short interest totalling 606,200 shares, an increase of 427.1% from the November 30th total of 115,000 shares. Currently, 1.2% of the company’s stock are short sold. Based on an […]

Protagenic Therapeutics, Inc. (NASDAQ:PTIX – Get Free Report) was the recipient of a significant drop in short interest in December. As of December 15th, there was short interest totalling 49,300 shares, a drop of 49.9% from the November 30th total of 98,400 shares. Currently, 0.8% of the shares of the stock are sold short. Based […]

Viracta Therapeutics, Inc. (NASDAQ:VIRX – Get Free Report) saw a significant increase in short interest during the month of December. As of December 15th, there was short interest totalling 3,000,000 shares, an increase of 89.9% from the November 30th total of 1,580,000 shares. Based on an average trading volume of 2,140,000 shares, the short-interest ratio […]